摘要
药品安全问题关乎公众身体健康,同时也考验着政府对公众生命安全的重视程度及监管能力。但是,从目前层出不穷的"毒药"事件可以得出结论,从药品的审批、流入市场后的信息公开及事后的跟踪召回制度并没有完善和很好地执行。将我国药品监管制度与当前较为成熟完善的美国FDA制度进行对比,借鉴先进的经验对我国药品监管制度的改进是非常有意义的。
Drug safety issues not only related to the health of the public,but also is a test of the the capabilities of government.However,from the endless ＂poison＂event,we can conclude that the system of drug approvel,imformation disclosure and drug recall is not perfect and perform well.It will be significant to learn the sophisticated experience of FDA system by comparing two different system.
出处
《特区经济》
2013年第7期73-75,共3页
Special Zone Economy
